Keresés

Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim

The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products

Treatment of hypertension. For the reduction of the risk of myocardial infarction (heart attack), stroke or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take A

Read about our patient-centric approach to cardiometabolic disease research.

Learn about new trends in equine health and get insights into the human-horse relationship!